In today’s study we demonstrated how the mix of mammalian target of rapamycin (mTOR) inhibitor RAD001 (everolimus) and Akt inhibitor MK-2206 exerted synergistic cytotoxic effects against low-phosphatase and tensin homolog (PTEN) gastric cancer cells (HGC-27 and SNU-601 lines). cytotoxic results from the co-administration. We noticed how the mix of RAD001 and MK-2206 exerted improved results… Continue reading In today’s study we demonstrated how the mix of mammalian target